Preparation of bromfenac-loaded liposomes modified with chitosan for ophthalmic drug delivery and evaluation of physicochemical properties and drug release profile

Asian Journal of Pharmaceutical Sciences

Volumn 8, Issue 2, 2013, Pages 104-109

  Tsukamoto, Toshimasa ^a   Hironaka, Kohei ^a   Fujisawa, Takuya ^a   Yamaguchi, Daiki ^a   Tahara, Kohei ^a   Tozuka, Yuichi ^a,b   Takeuchi, Hirofumi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Chitosan; Eye drop; NSAIDs; pH Gradient method; Surface modification

Indexed keywords

EID: 84930977180     PISSN: 18180876     EISSN: 2221285X     Source Type: Journal    
DOI: 10.1016/j.ajps.2013.07.013     Document Type: Article

References (18)

1. Ahuja, M., Dhake, A.S., Sharma, S.K., et al. Topical ocular delivery of NSAIDs. AAPS J 10 (2008), 229–241.
2. Araujo, J., Gonzalez, E., Egea, M.A., et al. Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine 5 (2009), 394–401.
3. Shen, J., Gan, L., Zhu, C., et al. Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect. Int J Pharm 412 (2011), 115–122.
4. Thrimawithana, T.R., Young, S., Bunt, C.R., et al. Drug delivery to the posterior segment of the eye. Drug Discov Today 16 (2011), 270–277.
5. Bochot, A., Fattal, E., Liposomes for intravitreal drug delivery: a state of the art. J Control Release 161 (2012), 628–634.
6. Eldaly, M.A., Styles, C., First versus second eye intravitreal ranibizumab therapy for wet AMD. Retina 29 (2009), 325–328.
7. Gan, L., Wang, J., Jiang, M., et al. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers. Drug Discov Today 18 (2013), 290–297.
8. Del Amo, E.M., Urtti, A., Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov Today 13 (2008), 135–143.
9. Hironaka, K., Inokuchi, Y., Tozuka, Y., et al. Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. J Control Release 136 (2009), 247–253.
10. Inokuchi, Y., Hironaka, K., Fujisawa, T., et al. Physicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eyedrop administration. Invest Ophthalmol Vis Sci 51 (2010), 3162–3170.
11. Sasaki, H., Karasawa, K., Hironaka, K., et al. Retinal drug delivery using eyedrop preparations of poly-L-lysine modified liposomes. Eur J Pharm Biopharm 83 (2013), 364–369.
12. Fujisawa, T., Miyai, H., Hironaka, K., et al. Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes. Int J Pharm 436 (2012), 564–567.
13. Izume, M., Ohtakara, A., Preparation of D-glucosamine oligosaccharides by the enzymatic hydrolysis of chitosan. Agric Biol Chem 51 (1987), 1189–1191.
14. Hironaka, K., Inokuchi, Y., Fujisawa, T., et al. Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage. Eur J Pharm Biopharm 79 (2011), 119–125.
15. Chiu, G.N., Abraham, S.A., Ickenstein, L.M., et al. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese. J Control Release 104 (2005), 271–288.
16. Takeuchi, H., Thongborisute, J., Matsui, Y., et al. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev 57 (2005), 1583–1594.
17. Volodkin, D., Mohwald, H., Voegel, J.C., et al. Coating of negatively charged liposomes by polylysine: drug release study. J Control Release 117 (2007), 111–120.
18. Li, N., Zhuang, C., Wang, M., et al. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 379 (2009), 131–138.